Open Demo Account
Home / Breaking News / Pfizer: No Evidence COVID-19 Variants Result in a Loss of Protection Provided by Vaccine

Pfizer: No Evidence COVID-19 Variants Result in a Loss of Protection Provided by Vaccine

Adel 25 February, 2021 5:06 pm Breaking News, Market Update

Pfizer announced on Thursday that they haven’t seen any evidence that circulating variants of the coronavirus result in a loss of the protection provided by the vaccine they developed with BioNTech, as reported by Reuters.

“We haven’t observed changes to neutralizing antibody levels that would predict a significant reduction in protection given by 2 doses of BNT162B2,” Pfizer noted.

Tags

Check Also

Market Drivers – US Session: After PPI Reading, US CPI Takes Center Stage, ECB “On Hold”

US Producer Price Index (PPI) inflation came in below expectations, bolstering bets of interest rate …

This site contains information and opinions for the purpose of providing only general information and can not be relied upon. The information and opinions contained in this Site shall in no way constitute an offer or solicitation to buy, sell or subscribe to any investment product. Users of this site shall bear any risks arising from the use of any information, opinion, program, service or material. Noor Trends reserves the right to make any change to the Site, the information, opinions, materials, products, programs, services or prices (if any) at any time without notice.
All copyrights reserved Noor Trends